Taysha Gene Therapies Inc (TSHA)

11:57 AM

Can Taysha Gene Therapies Inc. stock recover from recent declineMarket-leading capital gains - jammulinksnews.com

11:57 AM

Jul 23, 2025

What analysts say about Taysha Gene Therapies Inc. stockFree Market Dynamics Reports - Autocar Professional

Jul 23, 2025

Jul 23, 2025

What drives Taysha Gene Therapies Inc. stock priceUnrivaled growth potential - Autocar Professional

Jul 23, 2025

Jul 23, 2025

Taysha Gene Therapies Inc. Stock Analysis and ForecastFree AI-Backed Trading Signals - Autocar Professional

Jul 23, 2025

Jul 22, 2025

Is Taysha Gene Therapies Inc. a good long term investmentHigh-impact investment strategies - jammulinksnews.com

Jul 22, 2025

Jul 17, 2025

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives $8.17 Consensus PT from Analysts - Defense World

Jul 17, 2025

Jul 16, 2025

Taysha Gene Therapies (TSHA) Moves to Buy: Rationale Behind the Upgrade - Yahoo Finance

Jul 16, 2025

Jul 15, 2025

Why Taysha Gene Therapies Inc. stock attracts strong analyst attentionVerified Return Tips - Newser

Jul 15, 2025

Jul 15, 2025

What makes Taysha Gene Therapies Inc. stock price move sharplyFree Long-Term Wealth Growth Plan - Newser

Jul 15, 2025

Jul 15, 2025

How Taysha Gene Therapies Inc. stock performs during market volatilityFree Popular Stock Recommendations - Newser

Jul 15, 2025

Jul 13, 2025

How did TSHA's Q1 2024 EPS surprise impact short-term traders? - AInvest

Jul 13, 2025

Jul 13, 2025

Taysha Gene Therapies (NASDAQ:TSHA) Coverage Initiated at Bank of America - Defense World

Jul 13, 2025

Jul 12, 2025

Biotech Bargains: Finding Gold in the Healthcare Sell-Off - AInvest

Jul 12, 2025

Jul 11, 2025

Taysha Gene's 5.9% Surge: A Deep Dive into the Unexplained Rally - AInvest

Jul 11, 2025

Jul 11, 2025

BofA Securities initiates coverage on Taysha Gene Therapies stock with Buy rating - Investing.com Canada

Jul 11, 2025

Jul 11, 2025

BofA Assigns Buy Rating to Taysha Gene Therapies (TSHA) with $8 Target | TSHA Stock News - GuruFocus

Jul 11, 2025

Jul 10, 2025

Sarepta Therapeutics, Inc. (SRPT): A Bull Case Theory - MSN

Jul 10, 2025

Jul 08, 2025

Goldman Sachs Group Inc's Strategic Acquisition in Taysha Gene Therapies Inc - GuruFocus

Jul 08, 2025

Jul 03, 2025

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Li - GuruFocus

Jul 03, 2025

Jul 03, 2025

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Jul 03, 2025

Jul 03, 2025

Taysha Gene Therapies (TSHA) Gets a Buy from Wells Fargo - The Globe and Mail

Jul 03, 2025

Jul 01, 2025

Beyond The Numbers: 10 Analysts Discuss Taysha Gene Therapies Stock - Nasdaq

Jul 01, 2025

Jul 01, 2025

Taysha Gene Therapies (TSHA) Receives Buy Rating from Needham | - GuruFocus

Jul 01, 2025

Jul 01, 2025

Taysha Gene Therapies (TSHA) Receives Buy Rating from Needham | TSHA Stock News - GuruFocus

Jul 01, 2025

Jun 30, 2025

Cantor Fitzgerald Reiterates “Overweight” Rating on Taysha (TSHA) for Positive TSHA-102 Clinical Data - MSN

Jun 30, 2025

Jun 25, 2025

Rhumbline Advisers Boosts Position in Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - Defense World

Jun 25, 2025

Jun 24, 2025

Jefferies Maintains a Buy on Taysha Gene Therapies (TSHA) With an $8 PT - Yahoo Finance

Jun 24, 2025

Jun 22, 2025

Taysha Gene Therapies, Inc.(NasdaqGS:TSHA) added to S&P Biotechnology Select Industry Index - MarketScreener

Jun 22, 2025

Jun 14, 2025

Taysha Gene Therapies’ SWOT analysis: promising Rett syndrome therapy boosts stock outlook - Investing.com Australia

Jun 14, 2025

Jun 13, 2025

Taysha Gene Therapies price target maintained at $13 by Cantor Fitzgerald - Investing.com Canada

Jun 13, 2025

Jun 12, 2025

Taysha gene therapies stock rating reiterated by Cantor Fitzgerald - Investing.com Canada

Jun 12, 2025